Chemcon Speciality Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr +21.9% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
CS

Chemcon Speciality Chemicals Ltd

Q4 FY26Chemicals & Petrochemicals

Chemcon Speciality Chemicals Q4 FY26: Revenue ₹75.4 Cr, PAT ₹6.4 Cr

Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹75Cr
+37.4% YoY
+31.6% QoQ
Net profit
₹6Cr
+61.3% YoY
+25.1% QoQ
Margin
11.77%
+1.2 pp YoY
+0.2 pp QoQ

Based on Chemcon Speciality Chemicals Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹228
Market cap₹793 Cr
P/E28.1

The short version

Q4 FY26 Revenue from Operations: ₹75.4 Cr, a 37% YoY increase from ₹54.9 Cr in Q4 FY25. Q4 FY26 Financials (Page 9): - EBITDA: ₹8.9 Cr (54% YoY growth from ₹5.8 Cr in Q4 FY25) - EBITDA Margin: 11.8% (up from 10.5% in Q4 FY25) - Profit After Tax (PAT): ₹6.4 Cr (61% YoY growth from ₹3.9 Cr in Q4 FY25) - PAT Margin: 8.4% (up from 7.2% in Q4 FY25) - Margin Outlook:

From Chemcon Speciality Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

- Q4 FY26 Revenue from Operations: ₹75.4 Cr, a 37% YoY increase from ₹54.9 Cr in Q4 FY25. - Sales Volume for Q4 FY26: 3,497 MT, up from 2,210 MT in Q4 FY25 (organic chemicals 1,972 MT, inorganic chemicals 1,525 MT). - EBITDA for Q4 FY26: ₹8.9 Cr, up 54% YoY. - PAT for Q4 FY26: ₹6.4 Cr, up 61% YoY. - Export contribution rose to 71% in Q4 FY26 from 63% in Q4 FY25. **Outlook:** - Encouraging demand for newer products like Bromobenzene and 2-Bromo.

2 more points from Chemcon Speciality Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capacity Expansion: Commissioned P10 and P11 units adding new manufacturing capacity for organic chemicals (Page 23).
  • New Plant/Project:
  • Proposed P-10 unit expected Q1 FY27 (Page 21).
  • Proposed P-11 unit expected Q1 FY27 (Page 21).
  • Status:
  • P10 and P11 units successfully commissioned (Page 23).

2 more points from Chemcon Speciality Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Chemcon Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Chemcon Speciality Chemicals Ltd Q4 FY26 results — key figures

Chemcon Speciality Chemicals Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue7555+37.4%57+31.6%
Operating profit (EBITDA)96+53.4%7+33.3%
Operating margin11.77%10.55%+1.2 pp11.62%+0.2 pp
Profit before tax95+62.8%7+29.3%
Net profit (PAT)64+61.3%5+25.1%
EPS (₹)1.741.08+61.1%1.39+25.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemcon Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemcon Speciality Chemicals Ltd Q4 FY26 results?

Q4 FY26 Revenue from Operations: ₹75.4 Cr, a 37% YoY increase from ₹54.9 Cr in Q4 FY25. Q4 FY26 Financials (Page 9): - EBITDA: ₹8.9 Cr (54% YoY growth from ₹5.8 Cr in Q4 FY25) - EBITDA Margin: 11.8% (up from 10.5% in Q4 FY25) - Profit After Tax (PAT): ₹6.4 Cr (61% YoY growth from ₹3.9 Cr in Q4 FY25) - PAT Margin: 8.4% (up from 7.2% in Q4 FY25) - Margin Outlook:

What is Chemcon Speciality Chemicals Ltd share price analysis?

Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemcon Speciality Chemicals Ltd planning capital expenditure?

Capacity Expansion: Commissioned P10 and P11 units adding new manufacturing capacity for organic chemicals (Page 23).

Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.